Where does Seqirus UK Limited rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Seqirus UK Limited ranks #9,120 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Seqirus UK Limited hold?

Seqirus UK Limited holds 35 US utility patents granted between 2016 and 2025, spanning 9 technology areas.

What is Seqirus UK Limited's Innovation Score?

Seqirus UK Limited has an Innovation Score of 38.4 out of 100 (top 41% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Seqirus UK Limited's patent grant rate increasing or decreasing?

Seqirus UK Limited's recent grant velocity is -21% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Seqirus UK Limited's patents?

Seqirus UK Limited's patents average 18.9 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Seqirus UK Limited patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Seqirus UK Limited

Q: What technology areas does Seqirus UK Limited focus on?

Seqirus UK Limited's top technology area is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media) with 35 patents, ranking #304 of 4,144 assignees active in that subclass. Grants appear in 9 CPC subclasses total.

USPTO PatentsView assignee record - 35 granted patents across 9 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Seqirus ranks #9,120 of 49,997 tracked US assignees by granted-patent volume, with 35 patents across 9 technology areas.

#9,120
of 49,997 US assignees by volume: Top 41%
by Innovation Score (38.4/100): 18.9
avg claims per patent: -21%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R9120 · Foreign Corporation #9,120 · 35 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DOWN · BOOK-FULL

GRANTS-SMALL 35 grants
UPPER-Q #9,120/49,997
PHOTO-FINISH Safe Rack
CPC-NARROW C12N · 9 areas
INNOV-THIN 38.4/100
CLAIMS-RICH 18.9 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DOWN -21% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Safe Rack LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Seqirus’s 38.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 12.4 pts (32%) Velocity 4.1 pts (11%) Breadth 10.6 pts (28%) Claim depth 11.3 pts (29%)

Qualcomm Incorporated · highest

85
John Zink · near

38
Khalifa University… · near

38
Kissei Pharmaceutical · near

38
Rubicon Global… · near

38
Seqirus UK · this assignee

38
3D Lighting… · lowest

7

What this shows Seqirus's Innovation Score is 38.4/100 (top 41% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Seqirus?

Each dot is one of Seqirus’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Seqirus’s own 18.9 claims/patent is ABOVE the 13.3 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Seqirus vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Seqirus's grants concentrate

Seqirus UK Limited is a focused PatentsView assignee: 9 CPC subclasses with 100% of grants classified under C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media). Peak complete grant year is 2017 (7 grants) versus a trough of 1 in 2023. By volume, Seqirus sits between SSenStone Inc. and Soreq Nuclear Research Center.

Seqirus's three-year grant acceleration

Seqirus UK Limited shows 8 grants in 2022–2024 against only 13 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Ssenstone

35
Subsea 7 Norway AS

35
Safe Rack

35
Semiconductor Man…

35
Shandong Universi…

35
Sifotonics

35
Sling TV L L C

35
Soreq Nuclear Res…

35
Seqirus UK ◀

35

What this shows Seqirus holds 35 patents at rank #9,125, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Seqirus

By rank, the assignees closest to #9,125 in granted patent volume.

Leaders in C12N (Microorganisms OR Enzymes)

Other assignees with the most granted patents in Seqirus's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Seqirus, neither rank-band nor same-CPC leaders (those blocks stay above). In C12N (Microorganisms OR Enzymes), Seqirus ranks #304 of 4,144 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (38 here).

Kissei Pharmaceutical Co., Ltd. 38 Khalifa University of Science, Technology and Research 38 John Zink Company, LLC 38 Rubicon Global Holdings, LLC 38

Seqirus's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

38 Top 41% higher than 59% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Seqirus UK Limited patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	2	5.7%
2017	7	20.0%
2018	4	11.4%
2019	6	17.1%
2020	5	14.3%
2021	2	5.7%
2022	4	11.4%
2023	1	2.9%
2024	3	8.6%
2025partial year	1	2.9%

Which technologies does Seqirus UK Limited patent most?

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 35

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 35

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 28

C07K - Peptides 7

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 4

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 3

A61B - DIAGNOSIS; SURGERY; Identification 2

C12Y - Enzymes 1

Y02A - Technologies FOR Adaptation TO Climate Change 1

Top 9 of 9 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Seqirus UK Limited's patent record in context - here's where to go next.

Seqirus UK Limited's lead technology class is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media), 100% of its portfolio - see every assignee active in that class. Explore C12N
Ranked #9,120 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Seqirus UK Limited against SSenStone Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 38.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.